In vivo anti-tumor effects and other apoptotic mechanism (namely extrinsic pathway)-mediated by death ligands (e.g., FasL and TRAIL) are essential to elucidate the potential role of NK-exosIL−15/21 in HCC. The gene discussed is FASLG; the disease is neoplasm.